KCM
AGIO icon

Kennedy Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Kennedy Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
373,230
+97,774
+35% +$2.97M 0.25% 138
2026
Q1 		$9.32M Buy
275,456
+209,801
+320% +$5.95M 0.2% 181
2025
Q4 		$1.79M Buy
65,655
+41,014
+166% +$1.44M 0.04% 431
2025
Q3 		$989K Sell
24,641
-12,064
-33% -$454K 0.02% 500
2025
Q2 		$1.22M Sell
36,705
-26,248
-42% -$796K 0.03% 489
2025
Q1 		$1.84M Sell
62,953
-48,145
-43% -$1.6M 0.04% 442
2024
Q4 		$3.65M Buy
111,098
+81,971
+281% +$3.85M 0.08% 385
2024
Q3 		$1.29M Sell
29,127
-54,534
-65% -$2.48M 0.03% 569
2024
Q2 		$3.61M Sell
83,661
-75,627
-47% -$2.73M 0.08% 396
2024
Q1 		$4.66M Buy
+159,288
New +$4.27M 0.1% 338

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Kennedy Capital Management's AGIO Position: Q2 2026 in Review

Kennedy Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 35% in Q2 2026, buying an estimated $2.97M and bringing the position to 373,230 shares worth $13.9M. The position accounts for 0.25% of the portfolio, ranked #138.

Kennedy Capital Management first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Kennedy Capital Management held 373,230 shares of Agios Pharmaceuticals worth $13.9M as of Q2 2026.
  • Kennedy Capital Management bought 97,774 Agios Pharmaceuticals shares in Q2 2026, an estimated $2.97M.
  • Agios Pharmaceuticals made up 0.25% of Kennedy Capital Management's portfolio in Q2 2026, its #138 holding.
  • Kennedy Capital Management first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.